Medicared For All Logo

Matthew Cassell in Meridian, Mississippi

Home Mississippi Meridian

Matthew Cassell has Hematology/oncology as his primary medical specialty. Their primary office is: 1704 23rd Ave in Meridian, Mississippi.

They're a part of the: Meridian Oncology Associates Pllc medical group which has around 4 members. You can call their office at 601-482-1555 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Mississippi School Of Medicine and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Matthew W Cassell Office Phone and Directions

Matthew Cassell
Meridian Oncology Associates Pllc
1704 23rd Ave
Meridian, Mississippi 39301
601-482-1555


Patient Ratings
Please rate your experience with Matthew Cassell below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 601-482-1555


Enter a starting address:


Healthcare Info for Matthew Cassell

Medical School: University Of Mississippi School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Matthew Cassell is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 0749446128
NPI #: 1427269331
NPI Created On: 05/24/2007
NPI Last Updated Listed as: 10/22/2020
Primary Taxonomy Code: 174400000X
License Number:
20329
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Ambetter
  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, comprehensive group of blood chemicals
  3. Manual urinalysis test with examination using microscope
  4. Carcinoembryonic antigen (cea) protein level
  5. Ferritin (blood protein) level
  6. Iron level
  7. Iron binding capacity
  8. Lactate dehydrogenase (enzyme) level
  9. Psa (prostate specific antigen) measurement
  10. Blood test, thyroid stimulating hormone (tsh)
  11. Microscopic examination for white blood cells with manual cell count
  12. Complete blood cell count (red cells, white blood cell, platelets), automated test
  13. Complete blood cell count (red cells, white blood cell, platelets), automated test
  14. Immunologic analysis for detection of tumor antigen
  15. Immunologic analysis for detection of tumor antigen
  16. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  17. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
  18. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  19. Infusion into a vein for therapy, prevention, or diagnosis
  20. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225301

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225305

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225313

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788225315

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Hematology/oncology Professionals in Meridian

1704 23rd Ave
Meridian, MS
Meridian Oncology Associates Pllc

Providers in Meridian Oncology Associates Pllc

1.Matthew Cassell

1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology

2.Jennifer Eubanks

1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology

3.John Halbrook Md

1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology

4.John Voss Md

1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology

View all 4 members of Meridian Oncology Associates Pllc medical group